Former Goldman Sachs chief economist Jim O'Neill, who led the project, noted that in Europe and the United States alone around 50,000 people currently die each year from infections caused by superbug forms of bacteria such as E.coli.
"Unless something is done by 2050, that number could become 10 million people losing their lives each year from then onwards," he told a briefing in London.
O'Neill, who was asked by British Prime Minister David Cameron in July to take a global economist's view of the problem, said he feared the assessment of its $100 trillion impact may be too conservative.
"As big as that number might seem, it almost definitely underestimates the true economic cost," he said.
We at Kastus® believe that our living, working and healthcare environments need to form an essential defense against the spread of superbugs such as MRSA and E. Coli. Kastus® Technologies has developed a unique visible light activated antimicrobial coatings for all glass and ceramics substrates, we call it Log4+®.
Log4+® treated surfaces have been independently proven to achieve bacteria kill-rates in excess of 99.99% offering results that will help to protect people from the harmful effects of superbugs before they have to depend on post infection treatment.
Log4+® is unique in that it is visible light activated, contains no silver, is non-leaching, visually clear, permanent, hard wearing, chemically benign and is economical to produce.
High touch surfaces, glazing, ceramics tiles, toilets and washroom equipment can be made antimicrobial by having Log4+® applied as part of the manufacturing process forming a first line of defense and reducing the need to consume yet more antibiotics.
The full report titled "Review on Antimicrobial Resistance - Tackling drug-resistant infections globally" can be downloaded here: www.amr-review.org.pdf